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A combined method for quantitative analysis, along with suspect and non-target screening of per- and
polyfluoroalkyl substances (PFAS) was developed using ultra-high pressure liquid chromatography-ultra-
high resolution (Orbitrap) mass spectrometry. The method was applied together with measurements of
total- and extractable organofluorine (TF and EOF, respectively), to pooled serum samples from 1996–
2017 from first-time mothers living in the county of Uppsala, Sweden, some of which (i.e. 148 of 472
women sampled 1996–2012) were exposed to drinking water contaminated with perfluorohexane
sulfonate (PFHxS) and other PFAS until mid-2012. Declining trends were observed for all target PFAS as
well as TF, with homologue-dependent differences in year of onset of decline. Only 33% of samples
displayed detectable EOF, and amongst these samples the percentage of EOF explained by target PFAS
declined significantly (3.5% per year) over the entire study period. This finding corroborates prior
observations in Germany after the year 2000, and may reflect increasing exposure to novel PFAS which
have not yet been identified. Suspect screening revealed the presence of perfluoro-4-
ethylcyclohexanesulfonate (PFECHS), which displayed declining trends since the year 2000. Non-target
time trend screening revealed 3 unidentified features with time trends matching PFHxS. These features
require further investigation, but may represent contaminants which co-occurred with PFHxS in the
contaminated drinking water.Environmental signicance
The global occurrence of per- and polyuoroalkyl substances (PFAS) is of concern for both human and wildlife health. Among the >4000 registered PFAS, only
a few are commonly monitored, suggesting that exposure to these chemicals may be underestimated. The present work investigated temporal trends of suspect-
and target PFAS, along with extractable organic uorine (EOF) and total uorine (TF) in pooled serum (1996–2017) from a cohort historically exposed to PFAS-
contaminated drinking water. Declining temporal trends were observed for all target PFAS, demonstrating the positive impact of phase-outs and regulation,
along with local drinking water clean-up initiatives. However, target PFAS also accounted for a smaller fraction of EOF in serum from more recent years,
suggesting an increase in the relative contribution from some presently unidentied PFAS. Finally, non-target time trend screening revealed 3 unidentied
features which are suspected to be contaminants which co-occurred in the contaminated drinking water supply.ckholm University, Stockholm, Sweden.
.se
, Swedish Food Agency, P.O. Box 622, SE-
0007, 10405 Stockholm, Sweden
erinary Public Health, Swedish University
-750 07, Uppsala, Sweden
tion (ESI) available. See DOI:
f Chemistry 2020Introduction
Per- and polyuoroalkyl substances (PFAS) are a family of
synthetic compounds containing at least one fully uorinated
carbon atom in the alkyl chain.1 PFAS have been used since the
1950s in a wide variety of applications (e.g. reghting-foams,
food-contact materials, textiles, cosmetics, etc.) due to their
stability along with surfactant and surface protection proper-
ties.2 In the early 2000s, however, concerns were raised about
the toxicity, bioaccumulation, environmental occurrence and
persistence of some peruoroalkyl acids (PFAAs), in particularEnviron. Sci.: Processes Impacts, 2020, 22, 1071–1083 | 1071

































































































View Article Onlineperuorooctanoate (PFOA) and peruorooctane sulfonate
(PFOS).2 While production and use of PFOS and PFOA has been
reduced, the over 4600 registered PFAS which exist on the global
market3 has le questions regarding whether human and
wildlife exposure to these chemicals is being underestimated.
Moreover, recent organouorine mass balance experiments
have reported large quantities of unidentied extractable
organouorine (EOF) in human blood (15–67%)5 and wildlife
(68–90%).5–7
Non-target analysis or suspect-screening (collectively
referred to herein as ‘NTA’) workows offer the opportunity to
elucidate novel PFAS which may account for unidentied
organouorine in samples. The application of NTA workows
within PFAS research have been reviewed recently.8 There are
few examples of where NTA has been combined with organo-
uorine mass balance determination and only a single study9
which has applied NTA to elucidate novel PFAS in humans. In
that work, a case–control design was used to identify novel
features in the serum of reghters from Australia. However,
concentrations of PFOS and PFHxS ranged from 92–343 and 49–
326 ng mL1 in serum from reghters, which is in some cases
over 2 orders of magnitude higher than the general population.
Identifying novel PFAS within the non-occupationally exposed
population is considerably more challenging due to lower
serum concentrations, which necessitates very low detection
limits.
In the city of Uppsala, Sweden, residents in certain areas
received drinking water (DW) contaminated with PFAS up until
2012, when the contamination was mitigated.10 The contami-
nation was most likely due to release of PFAS from per-
uorohexane sulfonate (PFHxS)-based aqueous lm forming
foam (AFFF) used for reghting at the military training airport
Uppsala-Ärna until at least 2003.10 PFHxS was the most preva-
lent PFAA in the contaminated well water (median 83 ng L1),
followed by PFOS (median 47 ng L1), peruorobutane sulfo-
nate (PFBS; median 13 ng L1), and peruorohexanoate (PFHxA;
median 10 ng L1).11 Given the health-based guideline for
drinking water issued by the Swedish Food Agency (<90 ng L1
based on the sum of 11 PFAS), these concentrations are clearly
of concern.12 Through the POPUP study (Persistent Organic
Pollutants in Uppsala Primiparas), it was determined that 148 of
472 women (i.e. 31%) sampled 1996–2012 were exposed to PFAS-
contaminated drinking water until mid-2012. Exposure of this
population to DW contaminated with PFAS was linked to
increased PFAS concentrations in the serum of both mothers
and their children. However, given the number and diversity of
PFAS, it remains unclear as to whether the full extent of expo-
sure to PFAS has been elucidated.11,13,14
The present study builds upon prior targeted temporal trend
analyses carried out on the POPUP cohort (1996–2016)15,16 by
applying a combined target/suspect screening strategy together
with uorine mass balance determination to samples from the
entire cohort (1996–2017). To the best of our knowledge, this is
the rst study to combine uorine mass balance and suspect
screening in human samples. These new methodologies
provide a means of comprehensively assessing human exposure
to PFAS and the effect of local drinking water clean-up1072 | Environ. Sci.: Processes Impacts, 2020, 22, 1071–1083initiatives. Moreover, this approach offers the possibility to




Target PFAS included C4–C16 and C18 peruoroalkyl carboxylic
acids (PFCAs), C4–C11 peruoroalkyl sulfonic acids (PFSAs), 32
peruoroalkyl acid precursors/replacement PFAS (including (N-
alkyl substituted) peruorooctane sulfonamides/
sulfonamidoalcohols/acetates, polyuoroalkyl phosphate
esters (PAPs), uorotelomer sulfonates (FTSs), uorotelomer
acids (FTAs), peruoroalkyl ethers) and 8 branched isomers. A
full list, including abbreviations can be found in Table S1
(ESI†). In cases where isomers were quantied, branched
isomers were denoted as ‘br-’ and linear isomers as ‘lin-’; in
cases where multiple isomers were not reported, the measured
target was assumed to be linear. All standards and reagents
were purchased from Wellington Laboratories.
Recruitment and sample preparation
In the POPUP study, rst-time mothers (n ¼ 622) from the
general population living in Uppsala County were recruited
between 1996 and 2017. All participants donated a blood
sample 3 weeks aer delivery. Blood sampling was done using
9 mL Vacutainer® or Vacuette® serum tubes and serum was
stored at 20 C, at the Swedish Food Agency. For details about
recruitment and blood sampling see Glynn et al.17 and Lignell
et al.18 The study was approved by the local ethics committee of
Uppsala University, and the participating women gave informed
consent prior to inclusion in the study (ethical approval number
dnr 96114 and 2004:M-177).
For each year of recruitment, 1–3 pooled serum samples were
prepared, with serum from 6–25 individual mothers in each
pool (Table 1). Three separate analyses were performed on each
pooled serum sample: (1) targeted PFAS were measured in
0.5 mL serum using an acetonitrile (ACN) extraction followed by
a newly developed Ultra high performance liquid
chromatography-Orbitrap mass spectrometry (UHPLC-
Orbitrap-MS) method; (2) extractable organouorine (EOF)
was determined in 0.5 mL portions of serum using the same
ACN extraction as for targeted analysis (minus internal stan-
dards) followed by analysis by combustion ion chromatography
(CIC); (3) total uorine (TF) was determined in 150 mL portions
of serum which were analysed directly by CIC. Details of these
methods are provided below.
Sample extraction
Each serum sample (0.5 mL) was transferred to a polypropylene
centrifuge tube and spiked with 50 mL of internal standard mix
(see Table S1, ESI†). The extraction involved addition of 4 mL
acetonitrile, mixing using a vortex-mixer (Vortex-Genie 2 G560E,
Scientic Industries), placing the sample in an ultra-sonic bath
(USC-TH, VWR) and nally centrifuging (Stathmos C312). The
procedure was repeated and the two extracts were combined,This journal is © The Royal Society of Chemistry 2020










1996 19 3 6–7 30 (21–41)
1997 62 3 20–21 28 (21–37)
1998 74 3 24–25 29 (21–35)
1999 17 3 5–6 27 (21–31)
2000 20 2 10 30 (21–37)
2001 9 1 9 29 (22–35)
2002 31 3 10–11 30 (24–37)
2004 32 3 10–11 29 (20–34)
2006 30 3 10 30 (19–40)
2007 29 3 9–10 30 (21–39)
2008 30 3 10 29 (20–35)
2009 30 3 10 29 (22–39)
2010 30 3 10 30 (20–41)
2011 29 3 9–10 30 (21–38)
2012 30 3 10 29 (21–38)
2013 30 3 10 29 (22–39)
2014 30 3 10 30 (20–38)
2015 30 3 10 30 (22–38)
2016 30 3 10 30 (24–36)
2017 30 3 10 29 (21–34)
a Total number of serum samples from the specic sampling year.
b Mean age of the women donating blood during the specic
sampling year.

































































































View Article Onlinetransferred to a new vial, and concentrated down to 1 mL under
a stream of nitrogen (40 C; using a Turbovap LV from Biotage).
Extracts were subsequently puried with 25 mg graphitized
non-porous carbon (Supelclean™ ENVI-Carb™ SPE Bulk
packing purchased from Sigma-Aldrich) and 50 mL glacial acetic
acid. Thereaer each sample was vortex-mixed (same model)
and centrifuged (Galaxy 14D from Stathmos), then 500 mL of
supernatant were transferred to a new vial. Lastly, 50 mL of
recovery standard mix (M8PFOS and M8PFOA) and 200 mL of
4 mM ammonium acetate in water were added prior to instru-
mental analysis.
Instrumental analysis
The extracts were analyzed using a Dionex UltiMate 3000
Ultrahigh performance liquid chromatograph (Thermo Scien-
tic) coupled to a Q Exactive HF hybrid Quadrupole-Orbitrap
mass spectrometer (Thermo Scientic) (detailed parameters
are listed on Table S2, ESI†). Separation of analytes was carried
out using an injection volume of 5 mL into a BEH C18 column
(2.1  50 mm, 1.7 mm particle size; waters) with a guard column
BEH C18 (2.1 5 mm, 1.7 mm;Waters). In addition, an “isolator
column” XBridge™ C18 (2.1  50 mm, 3.5 mm; Waters) was
mounted before the injector. Mobile phase A consisted of 95%
puried milli-Q water and 5% acetonitrile with 2 mM ammo-
nium acetate while mobile phase B consisted of 95% acetoni-
trile with 2 mM ammonium acetate and 5% puried milli-Q
water. A gradient elution with a ow rate of 0.4 mL min1 was
applied. The initial conditions were 90% of solvent (A) and 10%
of solvent (B). The percentage of B was linearly increased to 80%
from 1 min to 8 min then increased sharply to 100% at 8 minThis journal is © The Royal Society of Chemistry 2020and held at 100% B until 11 min. Initial conditions at 90% A
10% B were regained quickly aer 11 min and held until 13 min
for column equilibration. All samples were run in negative
ionization, full scan mode (200–1200 Da) at a resolution of
120 000 full width at half maximum (fwhm) with data-
dependant MS2 fragmentation using an inclusion list
comprising 453 suspects from the NORMAN list plus 62 tar-
geted compounds (50 of which authentic standards were
available), 22 internal standards and 2 recovery standards (a full
list is provided in Table S1, ESI†).
Targeted data processing was carried out using TraceFinder
version 4.1 (Thermo Scientic Version). A 9-point calibration
curve (0.01–150 ng mL; linear, 1/x weighting) was used for
quantication of target PFAS. The lowest concentration cali-
bration standard for which a well-shaped peak (i.e. a bell curve
with minimum peak/noise ratio over 3 and without substantial
signal observable in the blanks) was used as the limit of
quantication (LOQ). Solvent blanks were injected regularly
throughout the run to verify that carry-over was negligible.
Where a signal was observable in procedural blanks, the LOQ
was dened as the mean concentration detected in the blanks
plus three times the standard deviation of the blanks.
Targeted method validation, intercomparison, and ongoing
QC
Initial validation of the newly developed UHPLC-Orbitrap
method was carried out using replicate spike/recovery experi-
ments (2.5 ng of individual PFAS spiked into 0.5 mL serum; n ¼
4) along with analysis of NIST standard reference materials (n¼
2). Thereaer, a method intercomparison was conducted
whereby duplicate spiked samples and n ¼ 20 individual
(unspiked) human serum samples were processed by each of 3
methods: method A involved an ACN extraction (described
above) followed by analysis using the newly developed UHPLC-
Orbitrap method. Method B utilized the same ACN extraction as
in method A, with analysis by ultra-performance liquid chro-
matography tandemmass spectrometry (UPLC-MS/MS; see ESI†
for details). Finally, method C utilized a previously reported
solid phase extraction (SPE) procedure combined with UPLC-
MS/MS analysis, and was designed for an expanded suite of
PFAS, including polyuoroalkyl phosphate diesters15 (see ESI†
for details). Following method validation, time trend samples
were processed together with extraction blanks (one per batch,
empty tubes processed in the same manner as samples) and
quality control (QC) samples (spiked and unspiked human
serum samples).
Fluorine mass balance
For measurement of extractable organouorine (EOF),
sample processing was the same as for targeted PFAS analysis
(i.e. using 0.5 mL of serum) but was performed without
addition of internal standards. Following extraction, samples
were analysed using a Thermo-Mitsubishi combustion ion
chromatograph (CIC), details of which can be found in
Schultes et al.19 A brief overview is provided here. For EOF
measurements, sample extracts (200 mL) were placed inEnviron. Sci.: Processes Impacts, 2020, 22, 1071–1083 | 1073

































































































View Article Onlinea ceramic sample boat containing glass wool. For TF
measurements, 150 mL of serum was weighed directly into the
sample boat. The samples were combusted at 1100 C under
a ow of oxygen (400 L min1) and argon mixed with water
vapor (200 L min1) for 5 minutes. Combustion gases were
collected in 10 mL water in an absorber unit (GA-210, Mit-
subishi), aer which an aliquot of the absorption solution
(200 mL) was injected onto the IC (Dionex Integrion HPIC,
Thermo Fisher Scientic) which was equipped with an anion
exchange column (Dionex IonPac AS19 2  50 mm guard
column and 2  250 mm analytical column, 7.5 mm particle
size) operated at 30 C. The mobile phase consisted of a single
hydroxide solution which was maintained at 8 mM for 9 min,
then increased linearly to 100 mM by 11 min, followed by
a 3 min hold and then back to 8 mM for equilibration (total
run time 20 min). The ow rate was set to 0.25 mL min1 over
the course of the run and measurement of uorine was ach-
ieved by conductivity detection.
Samples for EOF analysis were prepared together with
blanks and spiked samples (250 ng PFOS; n ¼ 4). EOF
concentrations in samples were recovery-corrected by
dividing each value by the average PFOS recovery measured
for spiked samples by CIC (i.e. 73%; RSD ¼ 6.1%). Additional
spike/recovery experiments (n ¼ 4; 1.1 mg sodium uoride)
conrmed that inorganic uorine was completely removed
during extraction (i.e. 0% recovery). For assessment of accu-
racy and precision of TF data, replicate standard reference
material (BCR®-461, uorine in clay; n ¼ 5) was analysed
(94% recovery; RSD ¼ 4.6%). For comparison to EOF and TF
data, individual PFAS concentrations are converted to uo-
rine equivalents using eqn (1).
CF_PFAS ¼ nF  MWF/MWPFAS  CPFAS (1)
where CF_PFAS (ng F g
1) is the concentration of the PFAS of
interest in equivalents of uorine, nF is the number of uorine
atoms on the molecule, MWF is the weight of 1 mol of uorine,
MWPFAS is the molecular weight of the PFAS of interest, and
CPFAS is the concentration of the PFAS determined using LC-MS/
MS.
The total known extractable uorine concentration
(
P
CF_PFAS; ng F g
1) was obtained by summing the uorine
concentrations from all individual PFAS (except peruoro-4-
ethylcyclohexanesulfonate (PFECHS), which was identied
later by suspect screening). Thereaer, the concentration of
unidentied, extractable organic uorine (CF_extr.unknown; ng F
g1) was determined by subtracting
P
CF_PFAS from the total
extractable organic uorine concentration (CF_EOF; ng F g
1),
according to eqn (2).
CF_EOF ¼
P
CF_PFAS + CF_extr.unknown (2)
The TF concentration (CF_TF; ng F g
1) is the sum of CF_EOF
and the total non-extractable uorine concentration (CF_non extr.;
ng F g1), as shown in eqn (3).
CF_TF ¼ CF_EOF + CF_non extr. (3)1074 | Environ. Sci.: Processes Impacts, 2020, 22, 1071–1083Time trends of target PFAS, EOF, and TF
For determination of sum (
P
) PFAS concentrations, values below
LOQ were replaced with 0. For evaluating time trends of indi-
vidual PFAS, concentrations below LOQ were substituted with
LOQ/O2. Time trends for EOF were only evaluated using samples
containing EOF above the detection limit since substituting with
LOQ or LOQ/O2 could lead to articial gaps between sum PFAS
and EOF concentrations. While it has been pointed out that
removing data below LOQ can lead to positive bias20 this was
mitigated by focusing on the percentage of known EOF (rather
than the absolute EOF), and the fact that samples with detectable
EOF were not just present at early or late time points (i.e. they
occurred throughout the study period). To test for signicant
changes in concentrations from 1997–2017, log-linear regression
analyses were carried out. An approach adapted from Sturludóttir
et al.21 was used for change-point (CP) analysis. Prior to CP anal-
ysis, the data were screened for outliers. Concentrations with
a residual from a regression line covering the entire time period
were excluded if the residual exceeded 3 times the interquartile
range (IQR) of all the residuals. This is a conservative approach
and only a few observations were excluded from the CP test. To
detect the CP, the entire time-series was repeatedly divided into
two sections with at least three years per section. Thereaer, log-
linear regression lines were tted to each section and the residual
variance was recorded for each combination. The combination of
regression lines that gained the smallest variance was compared
with a log-linear regression line for the entire study period and the
mean for the whole time period with F-tests. The degrees of
freedom were reduced to compensate for the less constrained
situation of two regression lines compared to a single regression
line. Only a single change-point was determined for each
substance because the time-series were generally too short for
several change-points. The median concentration for the tested
change-point year was included in both parts of the time series.
This is a conservative approach which reduces the inuence of
abrupt changes from one year to the next but may also reduce the
chance to detect signicant trends on either side of the change-
point. The two parts may not necessarily point in different
directions (i.e. increasing-decreasing) and may not show signi-
cant slopes separately (only signicant regressions lines were
plotted) but they still show a signicant decrease in residual
variance, i.e. they explain signicantly more of the variation in
contaminant concentration than the mean or a regression line for
the entire period. For time series without a signicant CP, log-
linear regression was carried out.Suspect screening
Suspect screening was carried out using Compound Discoverer
(CD) 3.0 (Thermo Scientic). Soware parameters are listed in
Table S3 (ESI†). CD handles peak alignment, peak picking,
blank subtraction and comparison with databases (suspect list
of exact masses and mzCloud). For the peaks matching
a molecular mass in the suspect list (within 5 ppm), the MS2
spectra were further inspected. The correspondence of the MS2
data from CD with the suspect compound was assessed in silico
with both Sirius and MetFrag.22,23This journal is © The Royal Society of Chemistry 2020

































































































View Article OnlineNon-target time trend screening
We previously utilized increasing time trends as a prioritization
strategy to identify emerging bioaccumulative contaminants in
human whole blood.4,24 In the present work, we postulated that
unknown substances co-occurring with PFHxS in the contami-
nated drinking water supply may mimic the time trends of
PFHxS. Therefore, we prioritized features with time trends that
matched PFHxS (i.e. increasing until 2010 then decreasing) in
our non-target data using Spearman rank correlation for all
features against PFHxS.Results and discussion
Quality control and method validation
Blank concentrations were typically below LOQ for most targets
and were not subtracted from samples. Method accuracy and
precision (assessed via spiking of 2.5 ng of individual PFAS into
0.5 mL serum; n ¼ 4) were excellent for most compounds, with
mean percent recoveries typically ranging between 70 and
130%. The exceptions were for FOSAA, 6:2/8:2 diPAP, 10:2
diPAP, and 3:3, 5:3 and 7:3 FTAs, which all displayed lower
average recoveries (21–63%) and PFBA, PFTriDA, PFTeDA
PFHxDA, PFOcDA, which displayed higher recoveries (147–
154%; Table S4, ESI†). The sub-optimal performance for these
targets is likely due to the absence of exactly-matched,
isotopically-labelled internal standards. Nevertheless, preci-
sion remained excellent for these substances, as seen in Table
S4 (ESI†), and therefore they were included in the analysis of
temporal trends. Measurements of NIST Standard Reference
Material 1957 revealed good consistency with certied concen-
trations and previous studies15,25,26 (Table S5, ESI†). Further-
more, deviation from the values in Gebbink et al. were mostly
under 13%, with the exception of PFDoDA (43%), PFTriDA
(38%) and FOSA (88%), which is attributable to the very lowFig. 1 Average sum PFAS concentrations measured for each year in
Concentrations below LOQs were replaced with 0.
This journal is © The Royal Society of Chemistry 2020concentrations of these substances in the NISTmaterial. Overall
these data indicate good performance of the method. Finally,
average internal standard recoveries ranged between 59 and
92%, with the exception of M4PFBA (5.9  1.8%), M3PFPeA (19
 4.2%) and M2PFHxA (35  13%; Table S4, ESI†).Method intercomparison
A comparison of data generated using the newly developed
UHPLC-Orbitrap method (i.e. method A) with two existing
methodologies (methods B and C; both involving a triple
quadrupole mass spectrometer), used in Glynn et al. 2015 (ref.
27) and Gyllenhammar et al. 2017 (ref. 10) revealed consistent
percent recoveries for spiked duplicates for targets which were
included in all 3 methods (Table S6, ESI†). The exceptions were
uorotelomer sulfonates, which displayed better overall recov-
eries and repeatability using the Orbitrap method, and PFBA,
which was over-reported using previous methods B and C
(albeit, over-reporting of PFBA was also noted during our initial
Oribtrap method validation; see Table S4, ESI†). Notably,
PFTriDA, PFTeDA, and FTSs displayed poor recoveries using
method C, likely due tomatrix-induced ionization effects, which
have been previously noted with this method.28 Determination
of monoPAPs was not possible using the Oribtrap method due
to the necessity of an ion pairing agent in the mobile phase
which was only used in method C. A comparison of n ¼ 20
unspiked serum samples using all three methods demonstrated
strong correlation coefficients between each method (r2 typi-
cally greater than 0.9 for substances detected by all three
methods), and slopes and intercepts of linear regressions which
were in most cases close to or not signicantly different from
ideal values (i.e. 1 and 0, respectively; Table S7†). Overall these
data further demonstrate consistency among methods. In
general, the biggest performance differences among methods
were observed for low-abundance substances (e.g. PFHpA, br-pooled human serum for PFAS detected in >30% of all samples.
Environ. Sci.: Processes Impacts, 2020, 22, 1071–1083 | 1075
Fig. 2 Temporal trends of individual PFAS (in units of ng g1 blood serum). Large circles represent annual geometric means, small circles
represent individual samples. Curves represent significant (p < 0.05) log-linear (red), and change-point (green) trends.

































































































View Article OnlinePFOA, PFBS, etc.), which were more consistently detected by the
Oribtrap method, due to lower LOQs (typically an order of
magnitude lower; see Table S8, ESI†).1076 | Environ. Sci.: Processes Impacts, 2020, 22, 1071–1083Target PFAS proles
Across all samples, concentrations were below LOQ for PFPeA,
PFDoDA, PFTeDA, PFHxDA, PFOcDA, MeFOSA, 11Cl-PF3OUdS,This journal is © The Royal Society of Chemistry 2020

































































































View Article OnlineNaDONA, 3:3 FTA, 5:3 FTA, 7:3 FTA, 4:2 FTS, 6:2/8:2 diPAP, 8:2
diPAP and 10:2 diPAP. PFDS, FOSA, EtFOSA, EtFOSE, 9-Cl-
PF3ONS, and 6:2 diPAP were detected intermittently (i.e. #10%
of all samples) and were therefore not investigated further. The
remaining targets were detected in >30% of samples.
Sum (
P
) PFAS concentrations ranged from 8.1 (2017) to 32
ng g1 (1999) and were dominated by PFOS, PFOA, and PFHxS
over the entire study period (Fig. 1). Considerable changes were
observed in the relative prole of these 3 PFAS over the study
period. For example, from 1996–2002, proles consisted
primarily of PFOS, followed by PFOA and PFHxS. Aer 2002,
a concomitant increase in PFHxS and decrease in PFOS led to
approximately equal concentrations of these homologues by
2010. Aer 2010, PFHxS and PFOS concentrations remained
approximately equivalent with the remaining 15–30% of the
prole made up of PFOA and longer-chain PFCAs. Notably, the
PFOS-precursors FOSAA, MeFOSAA, and EtFOSAA were clearly
observable from 1996–2002; thereaer the occurrence of these
substances declined rapidly and they were generally not
observable aer 2010 (Tables S9–S11, ESI†). A detailed discus-
sion surrounding the factors controlling inuencing the PFAS
prole are presented in the following sections.Table 2 Summary of time trend analysis. Ntot and Yrs indicates the numb
analysis; year refers to the range of years included; trend (%) refers to the
regression; 95% C.I. refs to the 95% confidence interval of the trend; P
required to detect an annual change of 10% with a power of 80%; LDT: lo
between-year variation at a power of 80%; CP refers to the year of the
Target Ntot Yrs Year
Log-linear re
Trend (%)
PFBA 56 20 96–17 3.8
PFHxA 57 20 96–17 2
PFHpA 57 20 96–17 5.2
lin-PFOA 57 20 96–17 4.9
br-PFOA 57 20 96–17 12
PFNA 57 20 96–17 1.7
PFDA 57 20 96–17 3
PFUnDA 57 20 96–17 2.4
PFTriDA 57 20 96–17 0.16
PFBS 56 20 96–17 0.57
lin-PFHxS 57 20 96–17 3.6
br-PFHxS 57 20 96–17 1.9
lin-PFOS 57 20 96–17 8.4
br-PFOS 57 20 96–17 9
lin-FOSAA 57 20 96–17 6.5
br-FOSAA 57 20 96–17 27
EtFOSA 57 20 96–17 16
MeFOSAA 57 20 96–17 28
EtFOSAA 57 20 96–17 8
6:2 FTS 57 20 96–17 9.6
8:2 FTS 56 20 96–17 3.8
EOF 19 12 96–16 0.86
TF 57 20 96–17 3.2P
PFAS (F-equivalents) 57 20 96–17 5.4
% EOF explained by PFAS 19 12 96–16 3.9
% TF explained by PFAS 57 20 96–17 2.3
PFECHSa 57 20 96–17 6.7
a Detected by suspect screening. Not included in F mass balance calculat
This journal is © The Royal Society of Chemistry 2020Target PFAS time trends
Among the PFSAs, statistically signicant (i.e. p < 0.05) upwards-
downwards trends were observed for PFBS, lin-PFHxS, br-
PFHxS, lin-PFOS, and br-PFOS, with change-points occurring
in 2007, 2011, 2010, 2001, and 2001, respectively (Fig. 2 and
Table 2). The increasing PFBS and PFHxS trends at the begin-
ning of the study period likely reect increased PFAS contami-
nation of the DW supply, originating from extensive use of
aqueous lm forming foams (AFFF) in certain areas of
Uppsala.11 The PFAS contamination of the DW production wells
was mitigated in 2012, but already in 2007 the DW distribution
system of Uppsala was changed resulting in lower average PFBS
and PFHxS concentrations in the areas that had previously
received a high proportion of the contaminated drinking
water.11 This change in DW distribution in Uppsala corresponds
to the CP of PFBS (in 2007), br-PFHxS (in 2010) and lin-PFHxS
(in 2011). The change-point of PFBS already in 2007 could be
explained by the fact that PFBS is the most mobile and least
biopersistent peruoroalkyl sulfonic acid investigated here
(serum elimination half-life of 25.8 days for PFBS vs. 1751 days
for PFHxS and 2662 days for PFOS)29,30 and its concentration in
human serum is therefore expected to respond more quickly toer of samples and number of years, respectively, used in the time trend
annual percent change in concentrations identified from the log-linear
(LR) is the P-value associated with the linear regression; YRQ: years
west detectable trend (% per year) for a 10 year period with the current
change point; P(CP) refers to the P-value of the change point
gression statistics Change-point statistics
95%
C.I. P(LR) YRQ LDT CP P(CP)
(9.6,2.4) 0.3916 35 50 2000 0.0381
(3.6,0.39) 0.0498 15 10 2000 0.4985
(6.4,3.9) <0.0001 13 7.9 2004 0.0077
(5.6,4.1) <0.0001 9 4.4 2002 0.0002
(13,11) <0.0001 15 9.8 2011 0.0537
(0.75,2.7) 0.0193 10 5.4 2007 <0.0001
(1.9,4.1) 0.0009 11 6.3 2004 0.0001
(1.5,3.4) 0.0005 11 5.5 2008 0.0011
(2.0,2.3) 1 18 13 2009 <0.0001
(2.3,1.2) 0.6718 16 11 2007 0.0005
(2.2,5.1) 0.0017 13 8.2 2011 0.0001
(0.08,3.9) 0.2375 17 12 2010 <0.0001
(9.0,7.8) <0.0001 9 3.9 2001 <0.0001
(9.8,8.3) <0.0001 10 4.8 2001 <0.0001
(7.5,5.4) <0.0001 12 6.4 2004 <0.0001
(30,23) <0.0001 31 37 2007 0.0017
(18,15) <0.0001 17 13 2009 0.0279
(30,26) <0.0001 22 19 2011 0.0001
(12,4.2) 0.0041 27 28 2004 0.1034
(12,6.9) 0.0005 22 19 2004 <0.0001
(9.6,2.4) 0.3916 35 50 2000 0.0381
(3.4,1.7) 0.5261 19 17 2004 0.6944
(4.5,1.8) 0.0033 13 8.3 2008 0.6517
(6.0,4.8) <0.0001 8 3.7 2001 0.0001
(6.7,1.1) 0.0252 21 19 2000 0.1585
(3.8,0.70) 0.0409 15 9.7 2009 0.1148
(7.2,6.1) <0.001 16 3.4 2000 0.011
ions.
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View Article Onlinedecreases in average exposure levels in 2007 than PFHxS
(change-point 2010–11). The slightly earlier change-point for
branched PFHxS isomers than of the linear isomer is likely due
to the faster blood elimination kinetics of the branched
isomers.11 The mitigation of PFAS contamination of the DW in
2012 explains the further decrease in PFBS and PFHxS towards
the end of the study period (Fig. 2). Overall, the declining
concentrations of PFHxS and PFBS highlights the effect of
mitigation efforts on exposure to PFAS via drinking water in
Uppsala. In contrast, the PFOS CP in 2001 likely reects the
phase-out of peruorooctane sulfonyl uoride-based
substances in the early 2000s, which is also reected in the
rapid decline of PFOS precursors (FOSAA, MeFOSAA, and
EtFOSAA) throughout the study period (average declines of 6.5–
28% per year). This sharp drop in PFAA-precursorFig. 3 Temporal trends of EOF, TF, and
P
PFAS (in units of ng F g1 blood
for by
P
PFAS, and % of TF accounted for by EOF. Large circles represen
Curves represent significant (p < 0.05) log-linear (red), and change-poin
1078 | Environ. Sci.: Processes Impacts, 2020, 22, 1071–1083concentrations highlights the rapid response to phase-out
initiatives in humans. Interestingly, the change-point for
PFOS observed in this study is considerably later than that
observed in human milk from Stockholm (1988), assessed
between 1972 and 2016,31most likely due to the additional PFOS
exposure from DW in Uppsala.11
Among the PFCAs for which temporal trend analysis was
performed, all but PFHxA and br-PFOA (which both declined
throughout the study period) displayed statistically signicant
upwards-downwards trends (Fig. 2). CPs occurred in the years
2000 (PFBA), 2002 (PFOA), 2004 (PFHpA, PFDA), 2007 (PFNA),
2008 (PFUnDA), and 2009 (PFTriDA) (Fig. 2 and Table 2). The
declining trends in PFOA from 2002 and earlier are consistent
with those of PFOS and likely also reect the 2002 3M phase-out,
when production of ECF PFOA (the source of branched PFOAserum) as well as % EOF accounted for by
P
PFAS, % of TF accounted
t annual geometric means, small circles represent individual samples.
t (green) trends.
This journal is © The Royal Society of Chemistry 2020

































































































View Article Onlineisomers) was halted, and eventually replaced by telomerized (i.e.
strictly linear) PFOA.32 The PFOA Stewardship Program, initi-
ated in 2006, may have also contributed to the observed
decline.33 The trends and CP for PFOA observed here also
coincide with those observed for PFOA in human milk sampled
from 1972–2016 in Stockholm (CP ¼ 2000).31 The change point
for C9, C11, C13 PFCAs (i.e. beginning 2007–2009) also indicates
that exposure sources of these PFCAs have been restricted, but
the delay relative to PFOA suggests that regulation of these
substances occurred later than PFOA. Notably, Land et al.
reviewed PFAS temporal trend data published up until 2015 and
concluded that there was no evidence for signicant declining
trends in PFNA, PFDA, PFUnDA, PFDoDA, PFTrDA and PFTeDA
in human sample at any global location.34 In the trend study on
human milk from Stockholm, PFDA and PFTriDA did not
display a change-point; instead these substances increased
throughout the study period, while PFUnDA showed a CP in
1984, albeit with non-signicant trends before and aer this
time. As mentioned before, differences in study design and
sampling frequency may contribute to discrepancies between
studies. The CP for PFNA in the present study (2007) is fairly
consistent with that in human milk (2010).
Finally, both 6:2 and 8:2 FTS displayed CPs in 2004
(upwards–downwards), but only 8:2 FTS was statistically
signicant. Over the entire time period, statistically signicant
declines were observed for both substances, at a rate of 8 and
9.6% per year, respectively. Few data are available on FTSFig. 4 (A) Temporal trend and structure of PFECHS. Large circles represe
Curves represent significant (p < 0.05) log-linear (red), and change-po
standard (bottom). (C) MS/MS spectrum of PFECHS in a real sample (top
This journal is © The Royal Society of Chemistry 2020temporal trends but a recent report highlighted the widespread
occurrence of FTSs in the Nordic environment, including sedi-
ment, groundwater, indoor dust and biota.35 FTSs generally
occur at low concentrations with the exception of samples
collected close to sites contaminated with AFFF. To the best of
our knowledge, FTSs have not been reported previously in
human serum from the Nordics; however, serum collected in
2009 from 50 individuals from the US contained 8:2 FTS at
concentrations ranging from <0.005–0.231 ng mL1 (detection
in >95% of samples) and 6:2 FTS at concentrations ranging from
<0.005–0.047 ngmL1 (detection in >54% of samples).36 Sources
of exposure to FTSs are thought to include commercial products
containing FTSs (e.g. AFFF) or uorotelomer mercaptoalkyl
phosphate diester (e.g. food packaging).36
A comparison of time trends reported here to those of Glynn
et al.,27 Gebbink et al.15 and Gyllenhammar et al.10 for the same
cohort shows good overall agreement with a few exceptions
(Fig. S1 and S2, ESI).† Among the carboxylic acids, PFOA, br-
PFOA PFNA, PFDA and PFUnDA are well correlated (Pearson r >
0.78) with data from previous studies (Fig. S1†). Time series for
PFBA and for PFHxA are poorly correlated due to low detection
in the present study and relatively large standard deviations per
year in previous studies. Correlation for PFHpA is also poor (r ¼
0.191), probably due to higher values detected for specic
years (notably 2002, 2007 and 2009) in previous studies. PFDA,
PFUnDA and PFDoDA show average correlation (r ¼ 0.43–0.64).
The trends are similar, but the deviations are high in both setsnt annual geometric means, small circles represent individual samples.
int (green) trends. (B) Chromatogram of PFECHS in sample (top) vs.
) versus standard (bottom).
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View Article Onlinefor most years. For PFDoDA, the present study found a similar
trend but with lower concentrations. For PFTriDA, this study
shows a steep increase around 2010 followed by a sharp
decrease whereas values from previous studies suggest a steady
increase throughout the period.
The correlation coefficients for sulfonamides (FOSAA,
MeFOSAA and EtFOSAA) and for PFOS (branched and linear)
measured in the present study vs. in previous studies were all
over 0.91 and displayed similar time trends, indicating good
accordance between the studies (Fig. S2†). The observed
values are close across studies for the mentioned compounds
except for FOSAA where the observations from this study are
about a third of the values recorded previously. PFHxS
(branched and linear) has a higher standard deviation per
year in both studies. This results in lower correlation between
the two study datasets (0.88 for PFHxS and 0.94 for br-PFHxS),
even though time trends in Fig. S2† show close accordance.
Correlations for PFDS and PFBS indicate poor agreement
between studies (0.12 and 0.28). The former can be
explained partly by limited observations prior to 2000 for this
study with large coefficient of variation. The latter arises
mainly from differences in the period 2005–2010. During that
period, both present and previous studies recorded slightly
higher values than during the rest of the studied period.
However, the increase was more marked in the present study,
leading to a discrepancy in the time frames, and thus, poorer
correlation.Table 3 Features selected matching the trend of PFHxS. Table
includes feature identification number (ID), exact mass of the neutral
species, Spearman's rho (r), retention time (RT; min), and a comment
regarding the identity of the feature and/or elements of the mass
spectra which provide clues to the identity of the feature
Trend matching PFHxS (Spearman's r > 0.5)
ID
Exact mass
(neutral) r RT (min) Comment
A1 422.2307 0.63 3.84
A2 396.2066 0.58 7.16 Cl isotope pattern
A3 436.3554 0.56 9.60
A4 463.9702 0.65 5.54 PFNA
A5 299.9503 0.65 3.76 PFBS
A6 663.9577 0.61 7.27 PFTriDA
A7 513.9667 0.54 6.00 PFDA
1080 | Environ. Sci.: Processes Impacts, 2020, 22, 1071–1083Finally, for 6:2 FTS, there were too few observations to
compare between the studies. For 8:2 FTS the correlation is high
for the comparable observations from 2007–2017. F-53B (9Cl-
PF3ONS and 11Cl-PF3OUdS) datasets are both widely spread
and show poor correlation.
Fluorine mass balance
EOF was above method detection limits (25 ng F g1 serum) in
only 33% of samples, hampering comparisons to TF and
P
CF_PFAS for the entire time period. Future work will focus on
lowering detection limits to improve applicability to the general
population. Nevertheless, some observations could be made by
focusing on samples with detectable levels of EOF. Among these
samples, the proportion of EOF explained by target PFAS ranged
from 11–75%. Signicant trends were not observed for EOF,
despite the fact that signicant declining trends in TF and
P
CF_PFAS were observed (3.2% and 5.4% per year, respectively;
Fig. 3 and Table 2). The lack of a trend in EOF and the declining
trends in
P
CF_PFAS resulted in a decline of 3.9% per year in the
percentage of EOF explained by target PFAS over the study
period (p ¼ 0.025). This implies that samples collected in more
recent years have a larger fraction of unknown EOF compared to
older samples. The percentage of TF accounted for by EOF also
increased signicantly (2.2% per year) indicating that, collec-
tively, known and unknown PFAS make up a larger percentage
of TF in more recent years. Overall these ndings corroborate
observations in human plasma from Münster, Germany, which
also showed an increasing proportion of unidentied organo-
uorine in samples collected aer the year 2000.7 We are
unaware of any PFAS not included in the present work which
display increasing time trends over the last decade in human
serum; therefore, the cause of this increase in unidentied
organouorine remains unclear at this time.
Suspect screening
During our initial examination of the suspect screening data,
a total of 5 exact masses were matched within 5 ppm mass error
to suspects in our database (excluding targeted compounds).
Subsequent inspection ofMS2 data for these features ruled out all
ve tentative assignments. This result was not completely
surprising, given the overall low PFAS concentrations in this
population. Nonetheless a follow-up investigation of our suspect
screening data using lower peak thresholds (carried out following
the original submission of thismanuscript) revealed the presence
of an exact mass (460.93423) and MS/MS spectra corresponding
to PFECHS. Aer obtaining a standard of PFECHS from
Wellington Labs (Guelph, ON, Canada) and running it together
with a serum sample, we conrmed the assignment (Fig. 4).
PFECHS concentrations ranged from approximately 0.06–0.28 ng
g1, which would contribute to only a small fraction (i.e. an
additional 0.03–0.21%) of our known EOF estimates (note that
our original EOF calculations did not include PFECHS). However,
since these concentrations are semi-quantitative they require
conrmation using a method validated for PFECHS. Our data
builds on the initial discovery of PFECHS in human serum from
Sweden by Weiss et al.37 by demonstrating that human exposureThis journal is © The Royal Society of Chemistry 2020

































































































View Article Onlineto PFECHS occurred primarily during the 1990s-early 2000s and
has been declining since the year 2000 (6.7% per year from
1996–2017; p < 0.001; Table 2). PFECHS was also detected recently
in 86% of Baltic sea water samples and was previously reported in
sh and surface water from Canada,38,39 water, sediment, and sh
from China,40,41 and water and snow from the High Arctic.42,43
According to De Silva et al. (2011), PFECHSwas used as an erosion
inhibitor in aircras and was phased out of production by the 3M
Co. in 2002 along with PFOS and other peruorooctyl-based
substances.38 The phase-out of this product appears to align
with our observed time trends in human serum from Sweden.
Overall, this nding highlights the value in collecting NTA
data that can be retrospectively mined. As PFAS databases are
further developed, the present dataset can be continuously re-
processed without re-analysing samples. The cost- and time-
savings associated with retrospective mining (as opposed to
sample re-analysis) represents a considerable advantage for
NTA-based workows.Non-target time trend screening
Four targets (PFBS, PFNA, PFDA and PFTriDA) and three uniden-
tied features (neutral masses 422.2307, 396.2066, and 436.3554)
displayed time trends matching that of PFHxS (Spearman's rho >
0.5; Table 3). Unfortunately, MS2 data were not collected for the
unidentied features, precluding structural elucidation. Never-
theless, it is notable that feature A2 (neutral mass 396.2066) dis-
played a chlorine isotope pattern. Previously Rotander et al.
reported Cl-PFHxS in Australian reghters who were exposed to
AFFF, but the exactmass of Cl-PFHxS did notmatch that of feature
A2.9While we cannot conrm that any of the unidentied features
were uorinated, the consistency of their time trends to PFHxS is
notable, and warrants further investigation.Conclusions
Overall, the PFAS concentrations in our cohort were fairly low,
despite receiving PFAS exposure additional to that of the
general population. Moreover, declining trends were observed
for all PFAS as well as EOF and TF, with homologue-dependent
differences in year of onset of decline. While uorine mass
balance data indicate that the full extent of exposure to PFAS is
not fully elucidated, further improvement in PFAS databases
will help to identify this missing organouorine. For now, we
detected one novel PFAS (PFECHS) and several unknowns
through suspect/non-target screening which should be
included/prioritized in future studies.Conflicts of interest
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